|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.49 USD | +0.58% |
|
-4.89% | +1.39% |
| 03-06 | Tylenol use among women dropped after Trump tied it to autism, Lancet analysis shows | RE |
| 03-05 | Barclays Adjusts Price Target on Kenvue to $19 From $18, Maintains Equalweight Rating | MT |
| Capitalization | 33.52B 29.3B 26.47B 25.33B 46.06B 3,101B 47.88B 316B 125B 1,481B 126B 123B 5,350B | P/E ratio 2026 * |
18.7x | P/E ratio 2027 * | 17x |
|---|---|---|---|---|---|
| Enterprise value | 41.05B 35.88B 32.41B 31.01B 56.4B 3,796B 58.63B 387B 153B 1,814B 154B 151B 6,551B | EV / Sales 2026 * |
2.64x | EV / Sales 2027 * | 2.54x |
| Free-Float |
99.66% | Yield 2026 * |
4.87% | Yield 2027 * | 4.99% |
Last Transcript: Kenvue Inc.
| 1 day | +0.58% | ||
| 1 week | -4.89% | ||
| Current month | -8.53% | ||
| 1 month | -6.47% | ||
| 3 months | +1.63% | ||
| 6 months | -4.16% | ||
| Current year | +1.39% |
| 1 week | 17.36 | 18.14 | |
| 1 month | 17.36 | 19.18 | |
| Current year | 16.56 | 19.18 | |
| 1 year | 14.02 | 25.17 | |
| 3 years | 14.02 | 27.8 | |
| 5 years | 14.02 | 27.8 | |
| 10 years | 14.02 | 27.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kirk Perry
CEO | Chief Executive Officer | 59 | 2025-07-13 |
Amit Banati
DFI | Director of Finance/CFO | 57 | 2025-05-11 |
| Chief Tech/Sci/R&D Officer | 57 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Larry Merlo
CHM | Chairman | 70 | 2023-04-30 |
Vasant M. Prabhu
BRD | Director/Board Member | 66 | 2023-05-03 |
Richard Allison
BRD | Director/Board Member | 58 | 2023-05-07 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.58% | -4.89% | -23.32% | - | 33.52B | ||
| +0.10% | -1.94% | -10.31% | +6.22% | 350B | ||
| +0.15% | -2.04% | -5.35% | +6.36% | 139B | ||
| +1.01% | -5.04% | -1.09% | +21.82% | 71.21B | ||
| +1.08% | -2.95% | -0.68% | -10.23% | 60.36B | ||
| +4.26% | -5.22% | +32.11% | -62.89% | 31.79B | ||
| -0.48% | -6.73% | -41.48% | -29.81% | 19.61B | ||
| +0.54% | -0.76% | -12.23% | -6.51% | 18.97B | ||
| -2.32% | -7.94% | +0.20% | +13.28% | 11.37B | ||
| -1.27% | -5.24% | -9.47% | -13.10% | 8.7B | ||
| Average | +0.36% | -4.28% | -7.16% | -8.32% | 74.51B | |
| Weighted average by Cap. | +0.42% | -2.84% | -7.19% | +1.87% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 15.54B 13.59B 12.27B 11.74B 21.36B 1,438B 22.2B 147B 58.11B 687B 58.33B 57.09B 2,481B | 15.95B 13.94B 12.59B 12.05B 21.91B 1,475B 22.78B 150B 59.62B 705B 59.85B 58.58B 2,545B |
| Net income | 1.82B 1.59B 1.44B 1.37B 2.5B 168B 2.6B 17.16B 6.8B 80.35B 6.82B 6.68B 290B | 2B 1.75B 1.58B 1.51B 2.74B 185B 2.85B 18.84B 7.46B 88.23B 7.49B 7.33B 319B |
| Net Debt | 7.52B 6.57B 5.94B 5.68B 10.34B 696B 10.74B 70.96B 28.12B 332B 28.23B 27.63B 1,201B | 7.01B 6.13B 5.54B 5.3B 9.63B 648B 10.01B 66.12B 26.2B 310B 26.3B 25.75B 1,119B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-03-13 | 17.49 $ | +0.58% | 19,221,925 |
| 26-03-12 | 17.39 $ | -1.47% | 26,381,010 |
| 26-03-11 | 17.65 $ | -1.73% | 19,059,671 |
| 26-03-10 | 17.96 $ | -1.10% | 30,105,464 |
| 26-03-09 | 18.16 $ | -1.25% | 29,336,888 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- KVUE Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
















